Literature DB >> 14827944

Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects.

G A PETERS, B T HORTON.   

Abstract

Entities:  

Keywords:  ERGOT PREPARATIONS; HEADACHE

Mesh:

Substances:

Year:  1951        PMID: 14827944

Source DB:  PubMed          Journal:  Proc Staff Meet Mayo Clin        ISSN: 0092-699X


× No keyword cloud information.
  20 in total

Review 1.  Medication overuse headache.

Authors:  Valerie Cheung; Farnaz Amoozegar; Esma Dilli
Journal:  Curr Neurol Neurosci Rep       Date:  2015-01       Impact factor: 5.081

2.  PROLONGED ARTERIOSPASM AFTER OVERDOSE OF ORAL ERGOTAMINE TARTRATE IN MIGRAINE.

Authors:  E BYRNE-QUINN
Journal:  Br Med J       Date:  1964-08-29

Review 3.  Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis.

Authors:  Andrew J Dowson; David W Dodick; Volker Limmroth
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 4.  Medication-overuse headache: epidemiology, diagnosis and treatment.

Authors:  Espen Saxhaug Kristoffersen; Christofer Lundqvist
Journal:  Ther Adv Drug Saf       Date:  2014-04

5.  Letter: Rebound migraine.

Authors:  N J Legg
Journal:  Br Med J       Date:  1974-05-11

Review 6.  Analgesic rebound headache. How great is the problem and what can be done?

Authors:  S D Silberstein; W B Young
Journal:  Drug Saf       Date:  1995-09       Impact factor: 5.606

Review 7.  Medication overuse headache in children and adolescents.

Authors:  Matteo Chiappedi; Umberto Balottin
Journal:  Curr Pain Headache Rep       Date:  2014-04

Review 8.  Medication-overuse headache: risk factors, pathophysiology and management.

Authors:  Hans-Christoph Diener; Dagny Holle; Kasja Solbach; Charly Gaul
Journal:  Nat Rev Neurol       Date:  2016-09-12       Impact factor: 42.937

9.  Ergot intoxication: historical review and description of unusual clinical manifestations.

Authors:  G C Merhoff; J M Porter
Journal:  Ann Surg       Date:  1974-11       Impact factor: 12.969

Review 10.  [Current diagnosis and treatment of migraine].

Authors:  H-C Diener; Z Katsarava; V Limmroth
Journal:  Schmerz       Date:  2008-02       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.